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Preface
This meeting was the fourth in a series of meetings on Neglected Zoonotic Diseases 
(NZDs). The ﬁrst meeting was held in 2005, when the priority was on gathering 
evidence and gaining an understanding of NZDs. Now 10 years later, substantial 
momentum and signiﬁcant volumes of evidence have been gathered by the NZD 
community. There are now proven pathways for control and even elimination of certain 
NZDs. Thus in 2014 the focus of our meeting moved ‘From Advocacy to Action’. 
The goal of this meeting was to showcase successful One Health programmes from 
across the world and identify ways to achieve the NZD control milestones as speciﬁed 
in the WHO roadmap2. 
As in previous meetings, One Health researchers and representatives from the animal 
and human health sectors worldwide came together to network and explore ways  
to extend current control interventions to new locations and to other NZDs. Health 
education and communication remain key tools for promoting awareness and advocacy 
around NZDs at all levels. 
Now they have returned to their home countries, it is our hope that the invited policy 
makers, funders and other stakeholders who attended will act as high level advocates, 
persuading others into action.
Indeed it is our hope that this report will also motivate you to increase your own 
commitment towards actions to control NZDs. 
It is time to move ‘From Advocacy to Action’ and remove the ‘N’ from Neglected 
Zoonotic Diseases for good.
The NZD4 organising committee
2  WHO’s 2012 Roadmap on accelerating work to overcome the global impact of neglected tropical diseases 
(NTDs) and Resolution WHA66.12 on NTDs adopted by the World Health Assembly in May 2013. 
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Executive Summary
The fourth International Meeting on the Control of Neglected Zoonotic Diseases 
(NZDs) was held on 19–20 November 2014. The meeting was ﬁnancially supported  
by the European Union seventh framework programme through the ADVANZ (Advocacy 
for Neglected Zoonotic Diseases) and ICONZ (Integrated Control Of Neglected 
Zoonoses) projects. It was hosted by WHO at its headquarters in Geneva, Switzerland, 
and opened by the Assistant Director-General, Dr Nakatani. 
NZDs are found in communities in low-resource settings across the world, where  
they impose a dual burden on people’s health and that of the livestock they depend 
upon. National governments are increasingly seeking to mitigate the impact of NZDs  
on their citizens by implementing control programmes to address these burdens.  
These initiatives have been strongly endorsed by the Food and Agriculture Organization 
of the United Nations, the World Organisation for Animal Health and WHO tripartite 
and ﬁnancially supported by members of the broader international community including  
the Bill & Melinda Gates Foundation, the UK Department for International Development, 
the European Union, the International Development Research Centre and the CGIAR. 
WHO’s 2012 Roadmap on accelerating work to overcome the global impact of 
neglected tropical diseases (NTDs) and Resolution WHA66.12 on NTDs adopted  
by the World Health Assembly in May 2013 have enhanced the visibility of zoonotic 
NTDs’ – notably rabies, cysticercosis, echinococcosis, human African trypanosomiasis, 
foodborne trematodiases and leishmaniasis. Although not speciﬁcally included in the 
WHO Roadmap, other diseases have been addressed by the NZD community such  
as anthrax, bovine tuberculosis, brucellosis and leptospirosis. 
Much of the initial momentum for action against NZDs was catalysed by the inaugural 
meeting on NZD control in 2005. Whilst the priority at that time was a need for 
evidence, a decade later the focus is on better implementation of proven pathways  
for control and mobilizing central governments and donors within broader health  
and development agendas. The fourth international meeting on NZDs acknowledged 
the momentum generated by the NZD community over the past decade, urging the 
more than 100 participants – including representatives from national governments, 
international organizations, academia, foundations, the private sector and NGOs –  
to exert their inﬂuence and focus on operations, especially for the NZDs included  
in the WHO Roadmap. 
Clear themes that emerged throughout this meeting were the need for political 
commitment, sustainable One Health collaborations and the identiﬁcation of local 
champions to drive community participation in control. Examples of programmes 
making signiﬁcant progress in the control of some NZDs, both at national and local 
levels from across three continents, were provided by many countries.
Dissemination of the knowledge gained through these programmes provides signiﬁcant 
encouragement to country partners that the control of NZDs can indeed be achieved 
with currently available tools. There are opportunities for innovative funding 
mechanisms to support NZD control outside traditional donor models, including 
initiatives stemming from national bodies and from the private sector. Whilst challenges 
undoubtedly remain regarding reﬁnement of control tools and their application in 
low-income settings, these should not prevent large-scale implementation of control 
programmes. There is now the opportunity to capitalize on the existing knowledge, 
experience and political will to move ‘From Advocacy to Action. WHO will continue to 
report progress and follow-up on actions recommended during the meeting through its 
Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTDs). 
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Welcome and  
scene-setting 
Attended by over 120 participants, the 4th International 
Meeting on the Control of Neglected Zoonotic Diseases 
(NZD4) was hosted by the World Health Organization 
(WHO) at its headquarters in Geneva, Switzerland,  
on 19–20 November 2014. 
The meeting was organized in collaboration with the Food 
and Agriculture Organization of the United Nations (FAO), 
the World Organisation for Animal Health (OIE) and the 
European Union’s 7th Framework Programme for research 
and innovation through the ADVANZ (Advocacy for Neglected 
Zoonotic Diseases) and ICONZ (Integrated Control of 
Neglected Zoonoses) projects.
1
Chronology of international meetings  
on control of neglected zoonotic diseases 
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Working relationships between 
neglected zoonotic diseases and 
neglected tropical diseases
Objectives of the meeting 
•  To showcase successfully 
implemented programmes  
and track their progress.
•  To identify ways in which the 
milestones for control of NZDs  
as speciﬁed by the WHO roadmap 
can be achieved.
•  To explore ways in which current 
control interventions can be 
extended to include other NZDs.
•  To identify ways in which  
awareness of NZDs can be 
enhanced through health education 
and communication programmes.
•  To launch the Pan-African platform 
for the prevention and control of NZDs.
•  To inﬂuence leaders, in particular 
key policy-makers and donors, to 
increase commitment to action for 
the control of NZDs.
The time is ripe to transform evidence 
into practical and feasible strategies 
scaled-up on the ground.” 
Dr Dirk Engels, Director  
WHO Department of Control of Neglected Tropical Diseases
The WHO Assistant Director-General  
Dr Hiroki Nakatani opened the meeting, 
recalling how past NZD meetings  
(2005, 2007 and 2010) have served  
as a platform for cross-cutting and 
multisectoral reﬂection that must be 
expanded in the future. While past 
meetings have focused on disease 
burden, research priorities and public 
engagement, Dr Nakatani reminded 
participants that the overarching theme  
of NZD4 was for scaled-up action. This 
requires translating the bulk of existing 
knowledge into implementable plans  
and programmes, advancing research  
and translating recommendations  
into practical, tailored and adapted 
interventions for endemic country settings. 
Dr Dirk Engels, Director of the WHO 
Department of Control Neglected Tropical 
Diseases, situated NZD control within  
the current NTD global health landscape. 
Reﬂecting on the currently available 
toolbox for NTDs, he stressed the need  
to expand vector control, veterinary public 
health and water, sanitation and hygiene 
(WASH) interventions. Recognizing the 
challenges of cross-sectoral collaboration, 
Dr Engels called for a ‘re-think’ to address 
the difﬁculties of packaging these more 
complex interventions to policy-makers 
and donors. He outlined how building 
evidence and proof of concept for NZD 
Neglected zoonoses within  
the WHO roadmap on neglected 
tropical diseases
Of the 17 neglected tropical diseases 
(NTDs) included in the WHO roadmap  
for lowering the public-health burden  
of NTDs (1), four are prominently 
zoonotic: Taenia solium cysticercosis, 
echinococcosis, foodborne trematodiases 
and rabies. Other NTDs with zoonotic 
aspects include Trypanosoma brucei 
rhodesiense human African 
trypanosomiasis, leishmaniasis and 
zoonotic schistosomiasis. Moving from 
advocacy to action emphasizes the 
strategic expansion of NTD programmes 
in countries where government 
commitment is forthcoming. NZDs fall 
under the remit of the WHO Strategic  
and Technical Advisory Group for NTDs, 
or STAG-NTD, the principal advisory 
group for NTD control reporting directly  
to the WHO Director-General. It has  
the mandate of advising WHO on global 
policies and strategies, including 
monitoring programme delivery and 
forging linkages with health interventions 
in other sectors. 
As a group of poverty-inducing diseases, 
NZDs negatively affect both livelihoods 
and human health with dramatic 
consequences. Built upon three previous 
meetings that highlighted the need  
to prioritize these zoonoses through 
research, integrated control and 
community-based approaches, NZD4  
was convened under the theme of ‘From 
advocacy to action’. The meeting focused 
on the ‘key ingredients’ needed to quickly 
expand and scale-up proven interventions. 
This introductory session set the tone for 
the remainder of the meeting, emphasizing 
the importance of intersectoral collaboration, 
context-speciﬁc interventions and strong 
political support. Presenters outlined 
crucial ways in which evidence can be 
effectively translated into appropriate 
policy frameworks in order to simultaneously 
save lives and secure livelihoods through 
the control of NZDs in Latin America, 
Asia, Africa and beyond.
Photo ©Banchob Sripa
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scale-up requires a dedicated ‘step-wise’ 
agenda. Focused investments that 
showcase successful scale-up for  
rabies, T. solium and echinococcosis  
will catalyse control of other NZDs, 
providing unique leverages for capacity 
and commitment.
Intersectoral collaboration and the 
WHO–FAO–OIE tripartite
Opening remarks were furthered by the 
WHO–FAO–OIE tripartite, represented 
by Dr Bernadette Abela-Ridder (WHO), 
Dr Katinka de Balogh (FAO) and Dr Alex 
Thiermann (OIE). These presentations 
highlighted the long history of cross-
sectoral collaboration spearheaded by  
the Tripartite, promoting good governance 
and disease prevention and control 
systems at the human–animal–
ecosystems interface. Dr de Balogh 
situated the role of the Tripartite in  
global leadership and technical expertise, 
where it acts as a ‘convening power’.  
The Tripartite is directly involved in the 
implementation of international standards, 
guidelines and recommendations  
through the WHO’s International Health 
Regulations, the OIE’s Performance of 
Veterinary Services tool and the FAO/
WHO Codex Alimentarius. Recognizing 
the ‘reactive’, donor-driven nature of past 
responses to disease threats, Dr de 
Balogh stressed that the Tripartite places 
great emphasis on strengthening existing 
health systems through coordination, 
infrastructure (for example, building 
surveillance and laboratory capacity)  
and human resources.
Moving the world closer to applying 
cross-sectoral approaches requires a 
combination of global leadership, national 
engagement and local impact. The 
opening remarks reiterated the Tripartite’s 
recent focus surrounding zoonotic 
inﬂuenza, rabies and antimicrobial 
resistance; for example, the 2013  
FAO–OIE–WHO World Rabies Day joint 
statement highlighting their commitment 
to rabies elimination. A high-level 
technical meeting to address health  
risks at the human–animal–ecosystems 
interface in Mexico in 2011 (2) focused  
on national-level actions and key elements 
for cross-sectoral approaches to foster 
working relationships and collaborative 
technical activities. The Tripartite has 
sought to ‘lead by example’, contributing 
to the global momentum of the One 
Health vision to inform effective action 
Participant  
feedback 
Clicker devices were distributed to all participants at the  
start of the meeting, in order to record their responses to  
a series of questions posed at the end of each session. 
Through utilizing the clicker methodology, it was possible to 
engage a broader audience in the discussions and to increase 
the organizing committee’s understanding of participants’ 
opinions on both the meeting administration and the topics 
discussed. The clicker responses were also useful in  
enabling the recognition of regional patterns and comparisons 
and in contributing to the identiﬁcation of realistic goals and 
resources for moving ‘beyond NZD4’. 
The clicker questions for session one were basic identiﬁer 
questions in order to gain a sense of participants’ representative 
regions and sectors of employment. The results indicated that 
the majority of the participants represented the African and 
European regions, the bulk of whom were working in either  
the academic/research or the national government sectors.
A Academic/research/think-tank
B National government 
C Private sector (for proﬁt)
D  Nongovernmental organization  
(NGO)/not for proﬁt (NFP)
E Multilateral agency/donor
Which sector does your main  
current occupation fall under?
A B C D E 0
10
20
A African Region 
B Region of the Americas
C South-East Asia Region 
D European Region 
E Eastern Mediterranean Region
F Western Paciﬁc Region
G Global
B C E F
Which WHO region do you feel  
you exert the most policy inﬂuence? 
A D G 0
10
20
30
30
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against NZDs through the use of strong 
governance structures, stakeholder trust, 
capacity strengthening, public 
communication and ﬁnancial support. 
Examples of national commitment  
to zoonoses control
Translating science into effective policies 
and action on the ground requires 
ministerial support at the highest levels. 
Professor Be-Nazir Ahmed, from the 
Ministry of Health and Family Welfare  
in Bangladesh, outlined the importance  
of national steering committees. He 
showcased how ministerial support drove 
the rapid but successful scale-up of a 
nationwide rabies control programme  
in Bangladesh that was ﬁnancially and 
logistically country-led. Despite resource 
limitations that often necessitate external 
support, drastic changes in NZD control 
at scale can be achieved through 
dedicated champions, ﬁnancial support 
and coordination at the national level. 
Dr Manoj Kumar Roy, Deputy Secretary of 
the Ministry of Health and Family Welfare 
in Bangladesh, reiterated the support of 
the Bangladeshi government in effective 
zoonoses control, which began more than 
a decade ago when pandemic inﬂuenza 
demanded emergency action. A long-term 
commitment to zoonoses control was 
generated by implementing a national 
strategy and action plan, which resulted  
in the training of thousands of health 
workers alongside the formation of a 
multisectoral taskforce that facilitated 
national coordination of activities using a 
multisectoral approach. The example from 
Bangladesh highlighted how pandemic 
preparedness has resulted in the 
transformation of government attention 
towards NZDs such as anthrax and rabies. 
Ministerial support was also emphasized 
by the Honourable Dr Bright Rwamirama, 
the Minister of State for Agriculture, 
Animal Industry and Fisheries in Uganda. 
The Minister stressed that although 
scientiﬁc tools may exist for many NZDs, 
endemic countries too often ﬁnd it difﬁcult 
to mobilize the strong leadership and 
public investment needed to catalyse 
change. The Coordinating Ofﬁce for 
Trypanosomiasis Control in Uganda 
(COCTU) is a unique example of the 
potential for endemic countries to develop 
collaborative institutions and coordination 
mechanisms within their national systems 
to effectively address NZDs. He pointed 
to the dramatic impacts of insecticide-
treated cattle, tsetse traps and the 
involvement of affected communities  
in reducing the tsetse population in 
Uganda, as testimony to Ugandan-driven 
successes. Dr Rwamirama concluded  
by emphasizing the need to take stock of 
past success and move forwards to build 
new national and regional platforms.
Conclusion
The objectives of NZD4 reﬂect the need to move research results into 
country settings that can be speciﬁcally adapted to their local contexts and 
needs. Dr Bernadette Abela-Ridder, Team Leader for NZDs at the WHO 
Department of Control of NZDs, emphasized the need for innovative 
thinking about how existing platforms, tools and strategies for control of 
NZDs can be extended, strengthened and better coordinated. 
In order to save lives and secure livelihoods through NZD control, the NZD 
community needs to move beyond peer-reviewed publications, placing 
at-risk populations at the centre of NZD activities.
Public-health strategies of the 
WHO roadmap on neglected 
tropical diseases 
Of the 17 NTDs, 7 are known  
to be fully or partially zoonotic.  
The WHO roadmap on NTDs  
outlines ﬁve public-health strategies 
to overcome NTDs:
1.  Large-scale preventive 
chemotherapy 
2. Intensiﬁed disease management
3. Vector control
4. Veterinary public health 
5. Water, sanitation and hygiene 
WHO is committed to strengthening 
capacity and scale-up of those 
interventions central to NZD 
prevention and control: vector 
control, veterinary public health 
services and provision of safe water, 
sanitation and hygiene.
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The value of intersectoral 
working – One Health 
The beneﬁts of intersectoral collaboration as guided  
by One Health are fundamental to the control of NZDs. 
The successful integration of One Health approaches 
into existing – and future – NZD programmes lies in 
strategic planning and the identiﬁcation of champions who 
can advocate control at ministerial and community levels. 
Several examples of successful, sustainable One Health 
platforms for NZD control exist across Africa, Latin America 
and Asia, inspiring the continued uptake and promotion of 
similar intersectoral approaches to address these diseases  
at the human–animal–ecosystem interface. 
Photo ©Nik Wood
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12
The WHO NZD website (http://www.
who.int/neglected_diseases/zoonoses/
en/) deﬁnes NZDs through the word 
‘neglect’, highlighting their occurrence  
in poor and marginalized populations in 
low-resource settings. In order to break 
transmission, NZD control requires 
integrated, strategic approaches that 
draw consultation from a wide range of 
stakeholders; synergy is key. From its 
initial application to the emerging viral 
zoonoses with pandemic potential, One 
Health has evolved to apply to disease 
situations that are more endemic and 
‘neglected’ in nature (1–3). One Health 
also goes beyond infectious disease control 
to incorporate the human–animal bond 
and, particularly in the developing country 
context, the societal value of animals that 
usually extends beyond their commercial 
worth. Whilst recognizing that the individual 
tools may differ according to the disease 
agent involved, One Health provides an 
overarching toolbox for the delivery of 
synergistic approaches to NZD control. 
The practical delivery of One Health 
requires innovation in order to showcase 
its principal concepts and potential 
applications. For example, the successful 
eradication of rinderpest and smallpox, 
despite not being zoonotic diseases, 
demonstrates how international agencies 
can work together to drive political 
commitment and encourage local 
community involvement in disease control. 
Rabies is another example of a zoonotic 
disease where there is increasing interest 
and political will to coordinate efforts 
towards a speciﬁc target, with initiatives 
such as the Partners for Rabies 
Prevention (PRP) of the Global Alliance 
for Rabies Control (GARC) promoting 
partnerships among private sector actors, 
national governments, international 
agencies and donors to achieve a One 
Health approach for the control of this 
disease. One Health is not new, but it 
brings a new momentum to the control  
of zoonoses that should be harnessed  
by NZD advocates.
Examples of intersectoral 
collaboration initiatives for 
zoonotic control from Africa  
and Latin America
Key messages from the session 
•  Whilst the application of One 
Health is not new, it brings a new 
momentum and new alliances to 
tackling zoonotic diseases.
•  The international NZD community 
has made admirable advances over 
the past decade; whilst 2005 saw  
a requirement for evidence, in 2014 
the focus is how to better package 
this evidence to attract central 
governments and donors.
•  Politically endorsed national 
structures can help facilitate and 
promote cross-sectoral surveillance, 
interventions and partnerships and 
should be encouraged across  
all regions.
•  Disease ‘champions’ drive buy-in 
and help facilitate communication 
between decision-makers and 
primary beneﬁciaries.
Launch of the Pan-African  
One Health platform on  
Neglected Zoonotic Diseases
The Pan-African One Health NZD 
platform was conceptualized through the 
ADVANZ project funded by the European 
Commission (http://www.advanz.org/). 
The platform arose from a recognized  
gap in the coordination of NZD activities 
across sub-Saharan Africa, where current 
activities are scattered, largely in the form 
of vertical approaches towards singular 
diseases such as anthrax or rabies.  
The platform therefore aims to identify  
and collaborate with these existing 
independent NZD networks, acting as  
an ‘umbrella’ forum to facilitate continuous 
dialogue with NZD stakeholders, 
including the affected communities  
who are very much part of the disease 
control process. Through harnessing  
the speciﬁc strengths of each disease-
speciﬁc network via a centralized 
platform, it is anticipated that lessons 
learnt and future opportunities for 
intersectoral collaboration can be readily 
promoted, enabling African stakeholders 
to control NZDs in a locally appropriate 
way. The platform is also expected to 
advocate for NZD control in the region, 
persuading decision-makers to coordinate 
sustainable policy approaches for NZD 
Building-up relationships within the 
One Health agenda is vital.” 
Professor Peter Holmes, Chairman 
Strategic and Technical Advisory Group for Neglected Tropical Diseases
Photo ©Christine Amongi Acup
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control. A further vehicle for achieving 
cross-sectoral collaboration and 
knowledge is a website containing  
One Health advocacy information material 
developed by the ADVANZ EU-project 
(http://advocacy.advanz.org).
The Zoonotic Disease Unit of the 
Government of Kenya  
(http://www.zdukenya.org/)
A series of key steps have moved the 
Kenyan government towards the 
realization of One Health, stemming  
from the multisectoral national inﬂuenza 
taskforce formed in response to the threat 
of H5N1 avian inﬂuenza in 2005. Kenya’s 
2006–2007 Rift Valley fever (RVF) 
outbreak saw this taskforce evolve into 
the RVF taskforce; it was permanently 
renamed in 2008 as the Zoonoses 
Technical Working Group (ZTWG)  
and has met quarterly ever since. The 
requirement to form a One Health ofﬁce in 
Kenya was recognized in 2011, resulting 
in a Memorandum of Understanding 
between the Ministries of Health and 
Agriculture, Livestock and Fisheries  
to form the Kenyan Zoonotic Disease Unit 
(ZDU), which is the Secretariat to the 
ZTWG. The platform is chaired on a 
rotational basis by the Director of 
Veterinary Services and the Director of 
Medical Services, with the mandate to 
provide technical advice regarding 
prevention and control of zoonoses in the 
country. The ZTWG is well-represented 
by national and international human and 
animal health sectors, including experts 
from the two line ministries, WHO, FAO, 
AU-IBAR, KEMRI, ILRI, CDC and KWS 
among others. A list of priority zoonoses 
has been prepared for Kenya, aligning 
with the revised Integrated Disease 
Surveillance and Response (IDSR) 
guidelines to incorporate diseases such 
as anthrax, rabies and RVF. To date,  
One Health has prompted collaboration 
between the human and animal health 
sectors for several prevention and control 
strategies, for example the rabies 
elimination strategy, a RVF contingency 
plan and risk mapping to identify national 
zoonoses hotspots. Challenges remain, 
however, including the implementation  
of One Health at the sub-national level 
and the low levels of awareness of the 
country’s zoonoses burdens by policy-
makers, resulting in inadequate ﬁnancial 
and technical resources.
Participant  
feedback 
Participants considered it to be equally important  
to focus on cross-sectoral collaboration at both the 
community and central government levels in order  
to achieve a One Health approach for NZD control.  
It was encouraging that the majority of respondents 
considered themselves to be either moderately or very 
active in current One Health platforms in their region. 
A  Proof of ﬁnancial advantages  
of a collaborative approach
B  Documenting and promoting  
One Health success stories
C  Cross-sectoral collaboration  
at the local community level
D  Cross-sectoral collaboration 
between central government 
departments and donors  
at the planning level
Which ‘building block’ do you feel is the 
most important for the promotion of cross-
sectoral collaboration in your region?
A B C D 0
10
20
A  One Health initiatives exist in my 
region, but I have no involvement
B Passive interaction only
C Moderate interaction
D Very active
E  I would like to be involved, but  
I am not aware of One Health 
initiatives in my region
B C
What level of interaction do you currently 
have with existing One Health initiatives 
(related to NZDs) in your region?
A D 0
10
20
E
30
30
In the United Republic of Tanzania,  
One Health approaches and activities 
are driven by the One Health Country 
Coordination Committee (CCC) in the 
Office of the Prime Minister.” 
Dr Julius Keyyu, Director of Research Development and Coordination 
Tanzania Wildlife Research Institute 
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The Coordinating Ofﬁce for 
Trypanosomiasis Control in Uganda
In Uganda, a multi-stakeholder institution 
established over 20 years ago still 
operates as a One Health model to this 
day. Uganda has a long history of 
trypanosomiasis and tsetse challenges, 
which reached dangerous levels in the 
1970s and 1980s. In 1986, the Uganda 
Trypanosomiasis Control Council (UTCC) 
was formed to help avert the threat of 
zoonotic T.b. rhodesiense to the human 
population at that time, with the 
Coordinating Ofﬁce for the Control of 
Trypanosomiasis in Uganda (COCTU)  
as its secretariat. In 1992, a parliamentary 
act was established to permanently insert 
UTCC and COCTU into the National 
Constitution; COCTU is therefore a good 
example of a One Health institutional 
platform embedded in government law, 
which ensures its sustainability (4).  
A major role of COCTU is to advocate for 
community empowerment, bringing One 
Health coordination closer to affected 
communities; the ﬁrst such centre was 
opened in northern Uganda on 14 
October 2014, with an aim to establish 
centres in all major HAT affected regions 
over the next 3 years. Through promoting 
the development of infrastructure to 
control and prevent human African 
trypanosomiasis at the centres 
themselves, for example community-level 
technologies such as mobile livestock 
spraying and the building of tsetse traps, 
the beneﬁts to livelihood from simultaneous 
control of both tsetse and trypanosomiasis 
can in turn contribute to the betterment  
of the broader society.
Addressing canine rabies and other 
neglected zoonoses in Latin America
The Pan American Health Organisation 
(PAHO) contribution to the control of 
dog-transmitted human rabies across 
Latin America and the Caribbean (LAC)  
is an example of how political will can 
drive regional coordination for the 
effective control of transnational NZDs. 
However, despite the very signiﬁcant 
achievements by the countries, the few 
remaining hotspots in the region are now 
the priority for canine rabies elimination. 
The LAC rabies scenario demonstrates 
the ‘last mile’ challenges of any disease 
elimination programme, when interest 
tends to wane once the disease no longer 
constitutes a public health concern and 
other priorities arise. Several lessons  
can be taken from LAC experiences in 
regional rabies elimination, such as the 
need for early recognition of the large 
regional heterogeneities in order to tailor 
approaches and help garner support 
between LAC countries. This is the 
current situation where rabies-free 
countries are contributing capacity 
building in the remaining rabies hotspots. 
Other NZDs such as visceral 
leishmaniasis are also of concern in the 
region, with regional activities targeting 
standardisation of risk indicators to 
populate a recently established 
epidemiological data management  
system for the region. Hydatidosis is also 
endemic in a number of Latin American 
countries, with regional initiatives 
including a ﬁve-country network that 
targets capacity building via training, 
advocacy via communications, and 
evaluation of processes to allow 
identiﬁcation of best practices. In order  
to strengthen integrated control actions 
against taeniasis/cysticercosis in endemic 
countries, PAHO has planned the ﬁrst 
steps to gather information from endemic 
countries on national capacity on 
prevention and control of cysticercosis/
neurocysticercosis in the region with  
the objective to develop a network in the 
Americas. The cysticercosis network  
in the Americas will be a platform for 
communication and south-south and 
north-south cooperation. 
Mission of the WHO 
Department of Control of 
Neglected Tropical Diseases 
on neglected zoonoses 
“ To reduce the burden of neglected 
zoonotic diseases on poor and 
marginalized populations in low-
resource settings by advocating for 
and strengthening their prevention 
and control through effective 
collaboration with strategic partners 
and relevant sectors”.
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Conclusion
Whilst exciting examples exist to date of intersectoral collaboration for NZD 
control, participants acknowledged the work yet to be done, particularly at the 
sub-national levels. Another challenge is how to maintain momentum during the 
‘last mile’ of disease control once interventions have demonstrated success. 
Convincing politicians and communities to support the necessary policy 
changes that evolve with this progression – for example, switching from mass 
vaccination of animal reservoirs towards risk-based assessments for action 
– will be a tough political decision. Intersectoral and multi-disciplinary approaches, 
such as the inclusion of health economics to justify policy decisions, will be 
integral to garner support from policy-makers and communities alike.
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Interventions for  
dog-borne zoonoses 
Elimination of canine-mediated rabies is a priority of  
the FAO–OIE–WHO tripartite. Recent rabies success 
stories motivate the possibility of global freedom from 
dog-mediated human rabies by 2030, with several recent 
interventions demonstrating effective and efﬁcient 
scaled-up control over wide geographical areas. 
Common themes underpinning these successes include 
political commitment and the promotion of community 
ownership and awareness. Echinococcosis advocates 
meanwhile have focused on building the global evidence 
base for this disease, standardizing the clinical approach  
to human case management in an effort to effectively 
highlight the scale of the problem in endemic countries.
Photo ©KZN Project: Daniel Stewart
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Current initiatives to control  
dog-borne zoonoses 
Action points for control  
of canine-mediated rabies 
•  Achieve a canine-mediated rabies 
free world by 2030. 
•  Support PAHO (Pan American 
Health Organization) and REDIPRA 
(Reuniones de Directores de los 
Programas Nacionales de Control 
de Rabia en América Latina) in  
the ﬁnal phases of dog rabies 
elimination in Latin America.
•  Implement the Stepwise Approach 
to Rabies Elimination (SARE)  
and the rabies blueprint in endemic 
countries of Africa and Asia. 
•  Channel rabies control interventions 
through improved coordination  
of global rabies actors.
•  Develop programmes around 
vaccine bank initiatives and promote 
rabies control networks in Africa 
and Asia.
•  Campaign for ﬁnancial support  
from both external donors and 
governments of relevant countries, 
realizing that success hinges on 
political commitment and support.
We [the KwaZulu-Natal project]  
started small, proved our point  
and grew bigger.”
Mr Daniel Stewart, Primary Animal Health Coordinator 
Pietermaritzburg, KwaZulu-Natal (KZN), South Africa
GARC [the Global 
Alliance for Rabies 
Control] must be 
congratulated for 
initiating World 
Rabies Day. It has 
made a huge change, 
putting rabies  
on the agenda of 
many countries  
and organizations 
where it was not 
present before.” 
Dr Katinka de Balogh, Senior Ofﬁcer 
Veterinary Public Health, Food and Agriculture 
Organization, Italy
Photo ©Franck Boué
Global partnerships for rabies control
More than 98% of human rabies cases 
are canine-mediated, with about 85% of 
the global burden borne by countries in 
Asia and Africa (1). Children aged under 
15 years are proportionally at higher risk 
of the disease, where a dog that is owned 
or known constitutes the most common 
route of exposure. Africa has the highest 
number of human rabies cases per 
inhabitant, mainly due to the lack of 
available and accessible human post-
exposure prophylaxis (PEP) and the low 
rate of canine vaccination. In Asia, despite 
the large amount of PEP distributed each 
year, this region also accounts for 
unacceptably high numbers of human 
rabies cases, with bite sufferers either not 
seeking PEP or not completing the course 
of treatment. The Asian situation is further 
complicated by the various perceptions  
of dog ‘ownership’ and the resulting large 
numbers of community dogs. 
The GARC together with the FAO has 
developed a Stepwise Approach towards 
Rabies Elimination (SARE), which links 
closely to the blueprint for rabies control 
(2). These outputs are intended to assist 
decision-makers and programme 
managers with developing and 
implementing practical, measurable and 
meaningful rabies prevention and control 
programmes. SARE has been developed 
as a tool to assist countries in the 
development of a national programme and 
strategy for sustainable rabies prevention, 
control, and eventually elimination (Fig. 
3.1). Another initiative of the GARC has 
been World Rabies Day, a recognized 
United Nations International Day that has 
improved the visibility of rabies, placing 
control on the agenda of many countries 
and organizations where it was previously 
not present. Another GARC initiative  
is the Partners for Rabies Prevention,  
or PRP, which promotes a diverse 
membership for rabies control from both 
the public and private sectors, including 
international organizations and donors, 
WHO rabies collaborating centres, 
research scientists and representatives 
from industry. 
Successful control of canine-
mediated rabies in Bangladesh  
and South Africa 
Paradigm shifts in rabies control in 
Bangladesh and the South African 
Province of KwaZulu-Natal (KZN) has  
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Fig. 3.1  
Reduction in number of human deaths and animal cases due to 
rabies since inception of KZN project, 2007–2014. The 2012 
‘spike’ in cases was caused by a concurrent FMD outbreak that 
interrupted canine mass vaccination.
©KZN Project: Daniel Stewart
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led to impressive results, with both 
strategies generating subsequent natural 
momentum. Prior to 2010, Bangladesh 
had no strategy for rabies elimination,  
no dog bite management centres  
and more than 80% of the estimated 
canine population of 1.2 million was 
unvaccinated, giving rise to the loss of 
more than 2000 lives annually through 
300 000–400 000 dog bites. The 
Bangladesh programme, anchored 
around a four-point plan (Box 3.1) saw a 
consistent reduction of rabies cases from 
2100 human cases in 2010 to 1400 
cases in 2013 and human rabies-free 
status in one municipality. 
The incursion in 1976 of rabies into  
KZN resulted in an ongoing rabies 
problem in one of South Africa’s most 
heavily populated provinces, with nearly 
500 canine cases recorded in 2007,  
and under-reporting in humans remaining 
high. In 2009, the KZN project started  
to address rabies in KZN province, 
supported by funding from the Bill & 
Melinda Gates Foundation (BMGF). By 
2014, canine rabies cases in the province 
had decreased to 37, with no human 
cases reported at this time, demonstrating 
the feasibility of human rabies elimination 
(Fig. 3.2). The KZN rabies project 
developed an adaptable working model  
by a process of evaluation, research and 
innovation for the elimination of human 
rabies through the control – and eventual 
elimination – of canine rabies. Standard 
operating procedures (SOPs) developed 
as part of the programme are published  
in the rabies blueprint.(2) 
One of the challenges of large-scale 
disease control programmes is 
dependence on a single stream of 
funding, either from donors or from a 
single Ministry, as was the case in KZN 
and Bangladesh respectively. Both case 
studies emphasized that evidence of the 
impact of control enhanced the political 
momentum to commit further budgetary 
allocations. In Bangladesh, the Ministry  
of Health ﬁnancially contributed to the 
mass vaccination of dogs, despite this 
being originally perceived as the remit  
of the Ministry of Agriculture. For KZN,  
the involvement of key global health  
actors such as BMGF and WHO added 
legitimacy to, and raised the proﬁle of,  
the programme; however, it was the 
success of the project itself that stimulated 
additional contributions by the government 
to promote self-sustainability. 
A dedicated platform from which to 
coordinate activities was also deemed 
important. Since 2010, Bangladesh has 
demonstrated this necessary paradigm 
shift in rabies control and elimination 
activities through the formation of national 
committees to oversee dog bite 
management (DBM) centres and mass 
dog vaccination (MDV) programmes. 
During 3 years of scale up, these activities 
have resulted in the coverage of more 
than 100 000 dogs across all district 
municipalities, accompanied by the 
capacity development of an impressive 
number of local health-care providers  
and MDV personnel across the country. 
The creation of a rabies ofﬁce in KZN 
provided a centralized operation point. 
The role of effective champions who take 
the cause seriously and engage with other 
organizations such as animal welfare 
groups was recognized as an important 
component of the KZN project. DBM  
was highlighted as a key component of 
both the Bangladesh and South African 
strategies, as experience proved it was 
difﬁcult to convince people to take on a 
large-scale dog vaccination programme 
without ﬁrst addressing dog bites (3). 
Finally, the Bangladesh and South Africa 
examples emphasized the notion of a parallel 
top down-bottom up or ‘top-bottom’ 
approach, whereby communication of 
Participant  
feedback 
A  Lack of public awareness  
that dog vaccination can  
prevent rabies 
B  Affordability/availability of  
an efﬁcacious dog vaccine 
C  Lack of/differing perceptions  
of dog ‘ownership’ 
D  People would rather go to 
hospital for PEP after a bite  
than rely on dog vaccine
E  Lack of ofﬁcial commitment  
by public-health authorities  
or veterinary services
F  Rabies is not an issue  
in my region
Why do you think dogs are not being 
vaccinated to prevent rabies in your region?
A B C ED F 0
10
20
30
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information should feed from the decision-
makers to the community and back up, 
simultaneously targeting ministerial actors 
and local communities. 
Improving awareness of the impact  
of cystic echinococcosis in Morocco 
and Mongolia
WHO is working towards the validation  
of effective cystic echinococcosis control 
strategies by 2020. The case studies  
from Mongolia and Morocco presented  
at NZD4 highlighted the complexity of 
control and the challenges to the 2020 
target posed by low resource allocation 
for this disease. A WHO-supported 
clinical management study of human 
cystic echinococcosis in an area of high 
endemicity was presented from Morocco, 
where the requirement for effective 
stakeholder collaboration for 
interdisciplinary surveillance and control 
of cystic echinococcosis involving 
community based approaches has  
been recognized. The objectives of  
the study included training local health 
professionals in the diagnosis and 
management of abdominal cysts, and 
evaluating the effectiveness of selected 
treatment. It was acknowledged that more 
work is required to bring this disease to 
the attention of policy-makers in Morocco 
in order to promote the importance of this 
disease along several points of the food 
value chain, including at meat inspection. 
In Mongolia, preliminary results from a 
WHO-commissioned situational analysis 
have highlighted that neither a national 
policy nor national guidelines for 
surveillance, prevention and case 
management of echinococcosis currently 
exist in the country, despite a high rate  
of underreporting in certain provinces. 
The future plan is to establish the burden 
and societal cost of cystic echinococcosis 
and to develop national SOPs on  
clinical approaches to diagnoses and 
patient management. 
The studies on cystic echinococcosis 
described at NZD4 were both in the  
early stages of gathering evidence in 
order to provide advocacy and make 
recommendations for control, rather than 
implementing interventions. Whereas  
for rabies the extent of the problem is 
understood and clear strategies and 
action plans exist, burden estimates and 
proven control approaches are still lacking 
for Echinococcus. Health education, 
control at-source and the improvement of 
clinical procedures are currently the main 
priorities as identiﬁed by the two studies 
presented at the meeting. Building control 
of cystic echinococcosis onto other 
operational disease control programmes, 
such as that for brucellosis in Mongolia, 
was proposed as a strategy to promote  
its control and reduce surveillance costs. 
Whilst the development of parallel rabies 
and echinococcosis control programmes 
is appealing, consideration is required 
regarding the different timescales for 
interventions of these two diseases given 
that rabies requires an annual booster, 
whereas praziquantel administration for 
control of cystic echinococcosis is every 
3 months. 
Conclusion
Several recent rabies success stories exemplify the potential impact of 
strong global advocacy on NZD control. The addition of practical tools 
such as SARE and the rabies blueprint helps countries to identify where 
they lie on the continuum of rabies elimination, providing operational 
guidance on all rabies control aspects. 
Achieving a canine-mediated human rabies free world by 2030 is an 
aspirational, but nevertheless possible, target. Conversely, the control  
of canine zoonoses such as Echinococcus has been hindered by a low 
political proﬁle, suspected high underreporting and a general recognition 
that control of this disease is complex, factors which may hinder the 
achievement of the WHO 2020 target. 
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Four-point plan for rabies 
control in Bangladesh 
1.  Advocacy, communication  
and social mobilization,
2. Dog bite management,
3. Mass dog vaccination,
4.  Dog population management with 
the goal to achieving elimination of 
rabies and certiﬁcation of rabies-
free status.
Without high-level political commitment, 
a country cannot achieve control  
or elimination of any disease.” 
Professor Be-Nazir Ahmed, Ministry of Health and Family Welfare, Bangladesh
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Control of neglected 
parasitic zoonoses 
The 2012 WHO roadmap on NTDs commits that by 2020, 
interventions for Taenia solium control will be scaled  
up in selected countries and that morbidity due to  
food-borne trematodiases will be controlled in all 
endemic countries. 
Examples of successful control programmes, utilizing currently 
available tools, were given for ﬁsh-borne trematodiases  
in Thailand and T. solium cysticercosis in Peru. It is now 
imperative to adapt and scale up possible control strategies  
in endemic geographical areas. 
Photo ©B. Sripa
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Recent examples of successful 
interventions for the control of ﬁsh- 
borne trematodes in Thailand and 
Taenia solium cysticercosis in Peru
Fish-borne trematodes such as 
Opisthorchis viverrini are a signiﬁcant 
cause of cholangiocarcinoma, one of  
the primary liver cancers of the bile duct 
in Asia, with Thailand having the highest 
incidence of this condition in the world. 
Culturally determined risk-factors such  
as raw ﬁsh consumption are deeply 
embedded in the indigenous rice–ﬁsh 
culture of the region. These parasites 
have co-evolved with humans for hundreds 
of years, multiplying quickly to infect other 
reservoir or intermediate hosts, including 
cats and dogs, and are highly effective at 
adapting to changes in the environment. 
These factors make control a difﬁcult 
challenge, with the lack of continuity in 
government policy and control activities 
constant barriers to sustainable, 
widespread control. 
The ‘Lawa project’ (1) is working with a 
transdisciplinary team in the north-eastern 
Lawa Lake region of Thailand, a ﬁsh-borne 
trematodiasis hotspot with a community 
prevalence of 67% before the initiation  
of control activities. A control strategy 
was devised in this area based upon the 
eco–health approach, integrating targeted 
chemotherapy in high prevalence areas 
with intensive community education, 
environmental monitoring and extensive 
community participation.
A door-to-door intensive community 
education programme utilized Thailand’s 
system of health volunteers, each of 
whom is responsible for 10–15 
households. School-based education was 
also implemented alongside targeted 
chemotherapy using praziquantel. During 
the period 2008–2014, the liver ﬂuke 
infection rate in the programme villages 
has declined to less than one-third from 
the baseline and all nine schools were 
classiﬁed as ‘liver ﬂuke-free’. In 2012,  
the prevalence in Cyprinoid ﬁsh species, 
which are the second intermediate host, 
was found to be less than 1% compared 
with a maximum of 70% during the 
baseline survey. The success of the Lawa 
project convinced the Thai government  
to launch a liver ﬂuke campaign in 2012 
based upon the eco–health approach  
and it is believed that this model can be 
applied to other food-borne parasites.
Promoting scale-up  
of pilot programmes 
Case study – the Lawa project: 
an eco–health approach to 
ﬁsh-borne trematode control 
•  The human liver ﬂuke Opisthorchis 
viverrini is a major cause of bile duct 
cancer in South-East Asia, driven  
by culturally determined behaviours 
such as consumption of raw-ﬁsh.
•  Lack of continuity in government 
policy and control activities  
has contributed to previous  
control failures. 
•  A prevalence of 67% was found in 
Lawa village in north-eastern Thailand.
•  Lawa village was provided with 
targeted praziquantel treatment  
and intensive community education 
with a parallel ‘liver ﬂuke-free 
school’ programme of treatment  
and education.
•  Ecological monitoring is a central 
aspect of this integrated programme.
•  Community prevalence declined  
to 16% and all 9 schools were 
declared ‘liver ﬂuke-free’ in 2012.
•  The prevalence in ﬁsh declined  
from 70% to 1% over 10 years.
•  The Thai government has based a 
national programme on this approach.
There will never  
be one solution  
that fits all, but 
interventions can 
always be selected 
and adapted.  
We must not let 
longstanding habits 
or short term money 
savings stand  
in the way of 
progress against 
these diseases.”
Dr Sarah Gabrïel,  
Institute of Tropical Medicine, Belgium
Photo ©L Thomas
Effective control of T.solium will require  
a one health approach with multiple 
interventions implemented simultaneously 
across sectors.” 
Professor Maria Vang Johansen, Professor in Parasitic Zoonoses, University of Copenhagen
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An example of successful control of  
T. solium was provided by Dr Armando 
Gonzalez of the National University of San 
Marcos in Peru. Financed by BMGF, the 
main objective of the Peruvian T. solium 
programme was to provide evidence that 
cysticercosis could be eliminated from the 
study area. A mass drug administration 
(MDA) campaign consisting of 2 g 
niclosamide at months 1, 5 and 9 was 
combined with anthelminthic treatment of 
pigs (30 mg/kg oxfendazole at months 0, 
2, 4, 6 and 8) and porcine vaccination 
with TSOL18 at months 4 and 8. One year 
later, 310 pigs were culled and ﬁnely 
dissected for the presence of cysts. 
Within the vaccinated areas, only two pigs 
had a living cyst and these were living 
within a cluster of non-complainant 
families where the pastor prevented any 
treatment being provided to pigs. The use 
of the TSOL18 vaccine was highlighted  
as an important tool to enable elimination 
to be sustained. The success of this 
project was attributed to the dual health 
and production beneﬁts of anthelminthic 
treatment in pigs, where farmers noticed 
weight gains of up to 5 kg in treated pigs 
at slaughter, thereby incentifying local 
communities to work with the project  
and improving compliance.
Outcomes of a WHO informal 
consultation on cysticercosis,  
17–18 July 2014 
Determining the optimum strategy for  
T. solium control and establishing a 
framework for the management of 
neurocysticercosis in resource-
constrained countries were the objectives 
of an informal consultation on cysticercosis 
held at WHO headquarters in Geneva  
on 17–18 July 2014 (2). As well as 
representation from the FAO–OIE–WHO 
Tripartite, research and public-health 
stakeholders from countries committed  
to undertake pilot projects for control of  
T. solium, including Brazil, China, Côte  
d’Ivoire, Madagascar and Viet Nam, 
attended the meeting. 
Extrapolation of the available data 
supports the current recommendations of 
a combined approach to T. solium control 
consistent with the Peruvian approach, 
comprising human MDA, porcine 
anthelminthic treatment and vaccination. 
Supportive measures such as health 
education were also highly recommended, 
although further validation of such 
strategies is needed. It was agreed  
that the current tools, technologies  
and understanding of the disease are 
sufﬁcient to begin the implementation of 
small-scale control programmes in several 
countries. A commitment to develop 
detailed country-speciﬁc programmes 
including assessments of data availability, 
needs forecasts and the availability of  
new tools would occur over the next  
12 months. This activity is currently being 
driven by a group of committed countries 
where there is political will to act.
Meeting participants also requested the 
establishment of a network open to willing 
country partners to support efforts to 
control cysticercosis. This network, 
representing Member countries, the 
research community, human and animal 
health sectors, international agencies and 
stakeholders from the NTD community,  
is now constituted and managed by  
WHO in collaboration with FAO and OIE. 
Its objective is to decrease disease 
transmission by addressing all aspects 
involved in the disease cycle and improve 
access to health services and disease 
management for people with taeniasis  
and neurocysticercosis (3).
Participant  
feedback 
Participants overwhelmingly identiﬁed T. solium as  
an important parasitic zoonosis in their region. 
A  Taenia solium cysticercosis 
B  Cystic Echinococcus  
(hydatid disease) 
C  Leishmaniasis
D  Zoonotic human African 
trypanosomiasis
E Foodborne trematodes
In your opinion, which of the following 
parasitic zoonoses is most under-reported  
in your area?
A B C ED 0
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20
30
It is important that these [WASH and 
NTD] sectors work together to reach the 
2.5 billion people who don’t have access  
to improved sanitation, to stop open 
defecation and ensure that when 
wastewater is used it is done safely.” 
Ms Kate Medlicott, WHO WASH
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Importance of collaborating  
with social research, hygiene  
and sanitation sectors to address 
neglected parasitic zoonoses 
The parasitic zoonoses discussed at 
NZD4 exemplify how supporting 
strategies such as improved sanitation 
may have an impact on disease burden. 
The collaboration of NTD and water, 
sanitation and hygiene (WASH) sectors  
is an example of One Health 
operationalization whereby NZD control 
can be integrated into wider programmes. 
Collaboration between the WHO NTD 
and WASH departments is being 
legitimized through a new organizational 
strategy to be released in 2015, arising 
from a recognized need for the two 
departments to ‘learn each other’s 
language’ in order to contribute to the 
control of these diseases. Whereas  
the NTD community talks of disease 
prevention, WASH talks of functionality, 
accessibility and affordability, with 
programmatic implementation often 
undertaken by private sector actors.
The integration of T. solium control within 
other NTD control activities was also 
discussed, with an acknowledgement that 
there are infrastructural areas where this 
integration may take place, for instance 
the potential for sharing staff and vehicles 
across control programmes. Integration  
of NZD control into existing animal health 
platforms (for example, combining 
TSOL18 with classical swine fever 
vaccine) was also raised as an example, 
but it was clear that integration may  
mean different things in different 
countries. A strong call was made to 
provide broad ranging extension services 
to communities that tackle many diseases 
simultaneously, rather than proposing 
vertical disease strategies or separate 
infrastructure for NZD control. 
Health education is a key component  
of control strategies for the parasitic 
zoonoses, although empirical data on  
its efﬁcacy are scarce. Moreover, many 
control programmes have not made full 
use of the latest advancements in social 
science and hence many educational 
tools are dated and somewhat 
inadequate. To tackle this issue for  
T. solium control, a new web-based health 
education tool has been developed under 
the EC-funded ADVANZ project (4), 
where initial data from the United 
Republic of Tanzania look promising.  
This platform will provide uniform training 
options and enable the teaching tools  
to be continuously improved. Although 
validation of educational tools is needed, 
experience from WASH indicates that 
there are many interventions that do not 
work without an educational message, 
whilst education alone will not work 
without the infrastructure.
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Conclusion
Concurring with a June 2014 WHO informal consultation on the control of 
T. solium, participants agreed that the NZD community is sufﬁciently ‘tool 
ready’ to commence control of the parasitic zoonoses discussed at NZD4. 
Despite impressive examples from isolated projects, integrated, sustainable 
and cost-effective programmes still require validation in most regions. This 
validation is urgently required so that we may adhere to the NTD roadmap 
targets on these important parasitic zoonoses.
There are countries with huge burdens 
of neurocystercosis that have strategies 
for control written but not implemented. 
We need to assist countries at a 
programmatic level and demonstrate 
success.” 
Dr Bernadette Abela-Ridder, Team Leader 
WHO NZD
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Forgotten bacteria:  
from silent suffering  
to recurrent epidemics 
The bacterial neglected zoonoses are not included  
in resolution WHA66.12 on neglected tropical diseases 
and have been described as the ‘forgotten neglected 
zoonoses’. The reason for this neglect is multifaceted; for 
example, in the African Region, human disease priorities 
are deﬁned by the Integrated Disease Surveillance and 
Response (IDSR) framework, where anthrax is the  
only bacterial zoonosis featured. 
On the animal side, anthrax, bovine tuberculosis and brucellosis 
are listed as OIE notiﬁable diseases, but the veterinary and 
food safety sectors fail to control these diseases at source. 
Despite their low level of political attention in endemic 
regions, successful evidence of One Health approaches 
towards their control does exist; for example in Mongolia, 
where the strong evidence bases generated by brucellosis 
research have resulted in national-level policy dialogue. 
Photo ©Felix Roth
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Forgotten but funded 
Despite their lower level of attention and 
lack of prioritization in endemic regions, 
work undertaken by ICONZ has shown 
that these diseases are nevertheless 
beneﬁtting from signiﬁcant investments  
in research (Fig. 5.1). For example, bovine 
tuberculosis and brucellosis are getting 
more funding than rabies, echinococcosis 
and cysticercosis combined, with more 
than €168 million being spent on anthrax 
research. Despite these ﬁgures, the  
type of research, and the intended 
beneﬁciaries, should be considered as  
it is often not those in endemic regions. 
For example, the research interest in 
brucellosis and anthrax is largely fuelled 
by their potential use as bioterrorist 
agents, rather than their impact on 
resource-poor economies. 
Intersectoral collaboration for control: 
the case of brucellosis in Mongolia 
The large-scale brucellosis intervention 
programme in Mongolia has demonstrated 
that synergies between the Ministry of 
Health and the Ministry of Agriculture  
are essential to success. Logistical 
cooperation in the form of joint transport, 
training, diagnostic analyses and data-
sharing all contributed to synergizing 
control of brucellosis in Mongolia.
Aside from the logistical challenges,  
the operationalization of One Health  
is also difﬁcult in terms of budgetary  
and ﬁnancial constraints, particularly in 
resource-poor countries where ministries 
are often reluctant or unable to share their 
budgets with others. The Mongolian case 
demonstrated that where the economic 
evidence regarding the beneﬁts and 
savings for disease control exists, 
government resources are more likely to 
be secured, particularly in the Ministry of 
Agriculture due to the livestock losses 
suffered from the disease (1, 2) (Fig. 5.2). 
On the human side, however, brucellosis 
remains neglected, with the Ministry of 
Health still seeking funding solutions  
for the payment of brucellosis treatment 
for human patients. 
A second common challenge for 
zoonoses control – particularly for the 
bacterial zoonoses where at-source 
control in livestock reservoirs is the most 
effective in breaking transmission – is that 
the livestock sector is simply a sub-sector 
of a much larger Ministry of Agriculture 
Current state of bacterial zoonoses 
control in Africa and Asia 
Reasons for neglect of the 
bacterial zoonoses
•  The current potential control options 
are not supported by an enabling 
policy framework in many endemic 
countries. For example, test and 
slaughter is the only at-source 
control option for bovine 
tuberculosis; however, this is not 
practical where compensation 
cannot be paid.
•  There are major gaps in the 
understanding and training of 
medical and veterinary professionals 
with regard to the diagnosis and 
control of bacterial zoonoses. 
•  These diseases are not being 
prioritized at a national level by the 
health or veterinary sectors, and 
hence no resources are being 
allocated for national programmes. 
•  Difﬁculties in achieving cost-sharing 
of control across sectors leads to 
difﬁculties in quantifying the extent 
of these diseases and the true levels 
of under-reporting.
We are lagging behind in terms  
of [recognition/prioritization] for 
anthrax, BTB and brucellosis.”
Dr Rudovick Kazwala, Faculty of Veterinary Medicine and Public Health  
Sokoine University of Agriculture
Photo ©Felix Roth 
The money [spent  
on bacterial 
zoonoses research]  
is not invested 
according to  
long-term public 
health needs,  
with current 
funding being 
mostly directed to 
research on zoonotic 
agents that can be 
used as biological 
weapons, such  
as anthrax.”
Dr François Meslin,  
WHO NZD 
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with many competing funding priorities. 
There is a further need to improve the 
visibility of the livestock sector within 
national agricultural programmes and – 
particularly for countries whose 
agricultural sectors rely on signiﬁcant 
external funding – among donor agencies 
(3, 4). In Mongolia, the Ministry of 
Agriculture was motivated to control 
brucellosis because of the potential  
for opening up livestock export markets;  
a reminder of the importance of the 
bacterial zoonoses in international trade 
sanctions. Despite advocacy in Mongolia, 
however, brucellosis is still not a priority 
for the Ministry of Health, although 
attempts have been made to include the 
disease in health insurance schemes. 
Declaring brucellosis as an occupational 
disease may open up new funding 
mechanisms to cover drug costs for  
the treatment of human brucellosis. 
Sustainability of control and risk  
of re-emergence 
In the 1960s, huge Soviet-led test and 
slaughter campaigns in Mongolia reduced 
the prevalence of brucellosis; however, it 
became obvious that this practice was not 
feasible in the nomadic setting. With the 
support of WHO, the authorities shifted  
to mass vaccination in small ruminants. 
Immunization levels were high enough to 
bring down prevalence but insufﬁcient  
to interrupt transmission; as soon as 
vaccination stopped, the small ruminant 
prevalence – and consequentially  
the human prevalence – resurged. 
Government authorities launched a  
new 10-year mass vaccination campaign 
in 2001, but again failed to interrupt 
transmission. A third vaccination 
campaign was implemented in 2010,  
with four million ruminants vaccinated 
since then with Rev1 and S19, ensuring 
that coverage was high enough to stop 
transmission. The veterinary sector is 
currently monitoring the impact of 
vaccination, but ﬁnances are limited as 
remaining funds are being concentrated 
on foot-and-mouth disease (5). Similar 
experiences of initial success interrupted 
by budget cuts have been described  
in other countries. 
Discontinuation of control programmes is 
not the only driver for recurrent epidemics, 
with the Syrian war situation illustrating 
how conﬂict is an important driver for 
brucellosis emergence (6). In 2007, the 
Fig 5.2
Distribution of the monetary beneﬁts and costs of brucellosis 
control in Mongolia
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Value of funding (€) identiﬁed for the eight neglected zoonoses, for the 
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Syrian Arab Republic was reported to 
have the highest global prevalence of 
human brucellosis, hypothesized to have 
remained high despite the dearth of data 
since the onset of war. The objective of 
the current study presented during this 
session is to characterize the brucellosis 
situation post-war and to track how the 
disease has moved with the movement  
of displaced people, who have taken  
their cattle with them to the bordering 
countries of Jordan and Lebanon. 
Global burden of brucellosis
A systematic review of publications on 
human brucellosis, commissioned by the 
Foodborne Disease Burden Epidemiology 
Reference Group (FERG), revealed that 
high-quality data on disease incidence 
was largely lacking outside of the Middle 
East and Eastern Mediterranean region. 
Based on strict screening criteria, only  
29 publications were of sufﬁcient quality 
for an analysis of disease incidence (7) 
(Fig. 5.3). Brucellosis incidence varied 
widely between and within countries, 
demonstrating that aggregated data at 
national or regional levels may not capture 
the complexities of disease dynamics, and 
consequently, at-risk populations or areas 
may be overlooked. A meta-analysis of 
clinical manifestations of brucellosis 
enabled the ﬁrst informed disability weight 
to be calculated for brucellosis (8). Based 
on these ﬁndings, FERG is preparing an 
estimate of the DALYs due to brucellosis, 
enabling the global burden of this disease 
to be better understood and evaluated. 
Fig 5.3
Location of Human Brucellosis seroprevalence/incidence studies  
that meet quality criteria for analysis of disease incidence (7)
No studies
1 study
3 studies
4 studies
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Participant  
feedback 
A  Taenia solium cysticercosis 
B Echinococcus (hydatid disease) 
C  Zoonotic leishmaniasis
D  Zoonotic African trypanosomiasis 
(sleeping sickness)
E  Foodborne trematodes such as 
liver ﬂuke
F  Rabies
G Anthrax
H  Bovine tuberculosis
I  Brucellosis
In your view, which of the following diseases 
shows the most promise for control in the 
next 5-10 years in your region?
A EB FC G ID H 0
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A brucellosis accreditation scheme 
targeting the commercial sector  
was introduced in Zimbabwe after 
veterinarians showed this disease  
was a major problem. A reduction in 
prevalence was observed; unfortunately, 
after the 1990s this scheme was no 
longer sustainable due to budget 
constraints and the disease shot up.” 
Professor Gift Matope, Faculty of Veterinary Science 
University of Zimbabwe
The results of FERG will be launched  
on World Health Day 2015 that will be 
dedicated to food safety (http://www.
who.int/campaigns/world-health-
day/2015/event/en/). 
Challenges of brucellosis diagnostics 
The lack of deﬁnitive clinical symptoms  
for brucellosis in both animals and 
humans necessitates laboratory 
diagnosis; however, the gold standard 
(bacteriology) is technically challenging 
– especially in resource poor contexts – 
therefore diagnosis usually relies on 
serology. Whilst not perfect, some 
serological tests are adequate if correctly 
standardized and implemented, proven  
by their key role in brucellosis elimination 
in numerous countries. 
It was emphasized that the need for 
‘conﬁrmatory’ testing depends on the 
epidemiological context and the species 
being tested. In areas where brucellosis 
vaccination is not practised, conﬁrmatory 
testing in animals is not necessarily 
required given existing serological tests 
are over 95% sensitive and almost 100% 
speciﬁc in the absence of vaccination  
and are robust and affordable. In humans, 
conﬁrmatory tests are only important if  
a person is found to be seropositive in  
a screening test and has compatible 
symptoms. It was also emphasized that  
all brucellosis tests need careful 
standardization and that this is the most 
common problem found in the use of 
these tests. Novel molecular tests are 
being developed but their usefulness in 
the ﬁeld has not been fully tested and 
further studies are required. 
Finding and correctly  
treating patients 
Under-diagnosis of brucellosis is a reality 
in many countries, with tests often not 
available and limited awareness of the 
disease among many health practitioners. 
Indirect information from several endemic 
countries of Asia and the Mediterranean 
basin suggest that for every reported 
human case another 25–50 cases remain 
unreported. While the emphasis on 
brucellosis burden has been on under-
diagnosis, over-diagnosis due to poorly 
standardized or obsolete diagnostic tests 
was also suggested to be an issue. 
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Conclusion
Control of brucellosis in Mongolia is an impressive example of how to 
operationalize One Health, largely achieved through building the evidence 
base on the cost–effectiveness of intersectoral control. Despite initial 
success, concerns regarding diminishing state ﬁnancial resources for 
disease control in both humans and animals are hindering the sustainability 
of this scheme.
Experience of brucellosis emergence during the Syrian war has illustrated 
that conﬂict is an important driver of disease emergence for many NZDs. 
There are also challenges surrounding diagnosis of bacterial zoonoses 
such as bovine tuberculosis and brucellosis where, particularly for 
brucellosis, the tests are not perfect but adequate if implemented  
correctly in a standardized way.
There is a need for better statistical 
and epidemiological training of 
researchers in endemic countries to 
improve the quality of research studies.” 
Dr Anna S. Dean, TME/TB Monitoring and Evaluation 
World Health Organization
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Lessons learnt from brucellosis 
control in Mongolia 
The long history of brucellosis  
control in Mongolia has highlighted, 
that to achieve sustainable control 
countries must:
1.  Use an approach adapted to  
the context
2.  Monitor the immunization  
process and feedback the results 
and recommendations to the 
policy-makers 
3.  Think long term not giving up 
prematurely and ensuring 
sufﬁcient funds.
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Financing for the  
neglected zoonoses 
Research is integral to reﬁning the tools for 
successful NZD control, with examples of ongoing 
ﬁnancial commitment to research and development 
from donors including the European Union and the 
UK government. 
However, in order to capitalize on these research 
investments, the results need to be translated into action  
at scale, which often requires signiﬁcant advance funding 
beyond the scope of a public funding body. Initiatives 
such as development impact bonds (DIBs), which 
harness private sector investment models that habitually 
place large amounts of ﬁnance up-front, can offer generic 
lessons for NZD control and potentially add value to 
traditional donor funded platforms. 
6
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Funding opportunities: from 
traditional donor mechanisms to 
the untapped potential of private 
sector investors
European Union funding to address 
NZDs: Research Framework 
Programmes and Development  
and Cooperation Actions 
The European Union has historically  
and increasingly provided funding under 
the Research Framework and the 
Development and Cooperation 
Programmes, the latter focused on 
developing countries. Different aspects  
of NZDs within the One Health approach 
have been supported by both of the above 
programmes. Activities related to the EU 
Research Framework Programme (RFP) 
are implemented via different instruments, 
ranging from the development of 
collaborative research projects to the 
implementation of coordination and 
support actions. The 7th EU RFP, which 
covered the period 2007 to 2013, has 
contributed to the funding of signiﬁcant 
ongoing coordination and horizontal 
projects in the ﬁeld of NZDs such as 
ICONZ, OH-NEXTGEN, ADVANZ, 
STAR-IDAZ and ANTIGONE [http://
cordis.europa.eu/home_en.html].  
Other 7th EU RFP funded projects  
such as ASKLEPIOS, HERACLES and 
AFRICOLEISH are good examples  
where speciﬁc NZDs are being targeted 
[http://cordis.europa.eu/home_en.html]. 
A large part of Horizon 2020, the EU RFP 
for the period 2014 to 2020, addresses 
seven ‘Societal Challenges’ that include 
research related to human and animal 
health and food security. The EU 
Development and Cooperation (DEVCO) 
Programmes address the control of NZDs 
through national, regional and global 
interventions. Through the DEVCO 
Programmes, the EU has been supporting 
and contributing to OH initiatives and 
achievements since 1990. Three key 
recent examples of this EU commitment 
are the initiatives INNOVATE (in  
South and Southeast Asia), HPED 
(co-implemented by FAO, OIE and  
WHO and with focus on the South Asian 
Associations for regional Cooperation and 
on the Association of Southeast Asian 
Nations) and VETGOV (in Africa) [https://
ec.europa.eu/europeaid/home_en]. The 
strategic programming of the EU funding 
provided under the Research Framework 
and the Development and Cooperation 
Programmes is continuous. The resulting 
speciﬁc topics and opportunities for 
funding, including the potential to address 
NZDs, are based on priority-setting 
exercises carried out in consultation  
with multiple actors and stakeholders. 
UK Biotechnology and Biological 
Sciences Research Council 
collaborative research programme  
on Zoonoses and Emerging  
Livestock Systems 
There are a multitude of animal health  
and zoonoses funding sources available  
in the United Kingdom, including 
universities with their own research 
funding mechanisms, charities of varying 
sizes and scope of inﬂuence, and several 
government sources including the  
UK Department for International 
Development (DFID) and the Department 
for Environment, Food and Rural Affairs 
(DEFRA). The ICONZ Neglected 
Key messages from the session
•  A paradigm shift is required from 
ﬁnancing ‘inputs’ to ﬁnancing 
‘outcomes’. 
•  Enhanced quantiﬁcation of the 
economic beneﬁts of NZD control 
will generate greater enthusiasm  
for funding.
•  Greater funding innovation is 
required; for example DIBs where 
the investment ‘risk’ is taken up by 
the private sector rather than the 
public purse. 
•  Affected countries themselves 
should consider how to best 
generate money from domestic 
sources, in addition to external 
donor funding.
•  There is a recognized requirement 
for greater funding transparency and 
better coordination of NZD control 
approaches to build upon – rather 
than duplicate – the progress that 
has already been made.
These types of innovative financing  
mechanisms make sure we are not  
just investing more, but investing  
more wisely…” 
Dr Christopher Fitzpatrick, Health Economist, WHO
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Zoonoses database produced  
by Liverpool University (http://www.
zoonosis.ac.uk/iconz) gives a good 
overview of global funding into research 
for the NZDs, highlighting a number  
of UK-funded projects. Of the UK 
organizations funding research, the 
Biotechnology and Biological Sciences 
Research Council (BBSRC) is one  
of the larger funders of animal health 
programmes, with 591 animal health 
projects funded during 2011–2013 at a 
total budget of £122 million. Of these, 32 
had a component addressing one or more 
of the NZDs (including leptospirosis). 
The recently launched ﬁve-year BBSRC 
programme ‘Research on Zoonoses and 
Emerging Livestock Systems’ (ZELS) is 
funded by several UK government funding 
sources including DFID, four Research 
Councils and the Defence Science and 
Technology Laboratory. With a budget of 
£20.5 million (US$ 33 million equivalent), 
the programme aims to reduce the impact 
of zoonoses on the poor and their 
livestock, whilst forging mutually beneﬁcial 
inter- and multidisciplinary research 
partnerships. All 11 projects will be 
working in partnership with each other, 
national government and research groups, 
and local level stakeholders, both in Africa 
and Asia. The research projects will also 
be closely linked to major international 
stakeholders such as the OIE, WHO, 
FAO and the EU, as well as learning from 
previous research projects such as 
ICONZ and ADVANZ. Field research 
activities will be rolled out in 10 countries: 
six in Africa and four in Asia. The grants 
consist of two forms: smaller topic-
speciﬁc grants of 3 years that review gaps 
in knowledge, including several NZDs 
such as brucellosis and hybrid 
schistosomiasis. The seven research 
partnership grants are larger, truly 
multidisciplinary projects of 4–5 years. 
Several have many research groups 
working together, also on a number of 
NZDs including brucellosis and bovine 
tuberculosis, with a postgraduate 
programme that will train a cohort  
of students. 
Funding for the future: the potential 
for private sector investment models 
There is an increasing need for the NZD 
community to transform research into 
action; leveraging private sector funding 
to realize this is one opportunity, with 
examples of public–private investment 
models such as social impact bonds 
(SIBs) gaining traction in other areas of 
development. The SIB model (Fig. 6.1) 
includes traditional donors such as 
USAID or DFID playing the role of an 
‘outcome funder’; actors prepared to  
pay for societal impact. There is also a 
delivery partner – for example a research 
institute – that has an evidence base  
for an effective intervention but not the 
required human and ﬁnancial resources  
to deploy the intervention at scale.  
Lastly, there are private sector investors, 
motivated by societal change and  
the possibility of making a return  
on their investment. To underpin  
such investments, it is necessary to 
identify robust and measurable results 
that can act as indicators for that  
societal change.
This type of model works in that private 
investors are persuaded to provide 
‘up-front’ funding, based on their 
willingness to pay for societal impact, in 
order to deliver the intervention at scale. 
The delivery partners then implement  
their operational plan, resulting in 
veriﬁable results that equate to impact. 
The government or donor outcome payer 
then reimburses the private sector the 
cost of the intervention; a form of payment 
by result. The resultant transfer of risk of 
Participant  
feedback 
A  Social ﬁnance and development 
impact bonds (DIBs)
B Multilateral donor agencies
C Local funding 
D National funding bodies
Out of the possible funding options 
discussed, which one do you feel will be 
most suited to NZD control in your region? 
A B C D 0
10
20
30
Fig. 6.1 
Overview of the social impact bond funding mechanism
© Dr Paul Coleman, H20 Venture Partners 2014, developed under funding  
from Research Into Results, University of Edinburgh
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operational failure from public purse to 
private investor is an important factor  
to note in the SIB model. If results are  
not reached, the private investor loses 
their money, hence this partner enforces 
rigour on the operational delivery, so that 
everyone is focused on success. 
For example, DFID-funded support with 
Edinburgh University and Social Finance 
(www.socialﬁnance.org.uk) is trying to 
design an operational plan for control  
of human African trypanosomiasis in 
Uganda, with the outcome (result) being  
a sustainable reduction in the level of 
human infective rhodesiense in cattle 
reservoirs (2). Rabies is also a promising 
model, given the strong evidence base 
and the relatively simple vaccine control 
intervention; the constraint is operational, 
not technical, therefore it should be 
relatively easy to implement at scale with 
the right frontloaded funding (Fig. 6.2).  
It also supports a One Health approach, 
with veterinarians, medical ofﬁcers and 
environmentalists all focused around  
the goal of outcome payment.
Conclusion
Research remains key to addressing the NZDs, with the requirement for research 
funding outputs to lead to change as highlighted by the London Declaration on 
NTDs. As well as an exciting number of upcoming public funding opportunities  
to address various NZD initiatives, donors are now also looking to bring private 
sector leverage alongside public investments, enabling new models of ﬁnancing 
that provide the necessary funding over a long enough timescale to deliver results. 
The current dialogue occurring in the NZD community around innovative 
ﬁnancing opportunities is timely, given the release in February 2015 of the third 
global report on NTDs, where a strong theme will be innovative investment 
mechanisms to overcome the burden of NTDs.
Fig. 6.2
‘Linking cash to epidemiology’: the example of rabies
“ The red line is R0 – how many secondary 
infections appear from a single infected dog. 
The goal is to take this red line below 1. For 
this you need ‘effort’ in the form of funding; 
depicted by the blue bars. You need to hit the 
disease as hard as possible at the start to 
reduce Ro below 1, then maintain it via 
surveillance and risk assessment. The cash 
ﬂow proﬁle described here is very well suited 
to a social ﬁnance model such as DIBs.”
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Beyond NZD4: progressing 
from advocacy to action 
The fourth international meeting on neglected zoonotic 
diseases brought together over 120 participants from all 
WHO regions. Representatives from academia, national 
government ministries, multilateral agencies and the 
private sector showcased the progress made in the  
10 years since the ﬁrst meeting was convened in 2005. 
During this time, the NZD community has progressed from  
a requirement for basic epidemiological data to a point at 
which control for many of these diseases may be feasible 
using the currently available tools. It is now time to capitalize 
upon this signiﬁcant progress and operationalize One Health 
to ‘remove the N from the NZDs’.
7
Participants of the fourth International Meeting on Neglected Zoonotic Diseases,  
World Health Organization Headquarters, Geneva, Switzerland. 
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Address the immediate priorities
Rabies and T. solium cysticercosis  
were identiﬁed as priority diseases by  
the majority of participants. This view  
is validated by the inclusion of these 
diseases on the 2012 WHO roadmap for 
NTD control and the targets set therein 
(1). Participants considered rabies to 
show the most promise for control within 
the next 5–10 years, likely inspired by  
the recent successful campaigns in 
Bangladesh and South Africa and the 
readily available toolbox for this disease. 
Despite the current priority to achieve  
the targets set by the NTD roadmap,  
other diseases are not being overlooked. 
Success stories such as the elimination  
of echinococcosis in Cyprus and New 
Zealand were cited as inspiration for 
control of a broad range of NZDs, along 
with the recognition that the lead may  
be taken by agencies other than the  
WHO for some initiatives. 
Address the gaps in knowledge 
Although much progress has been made 
in increasing the recognition of NZDs at 
an international level, it was agreed that 
underreporting is still a valid concern. 
Issues such as low levels of community 
awareness, limited diagnostic capacity 
and ineffective reporting systems continue 
to hamper fully understanding the burden 
imposed by these diseases. Opisthorchis 
viverrini – a major zoonotic cause of bile 
duct cancer in South-East Asia (2) – was 
highlighted as a key example of disease 
misclassiﬁcation, given global burdens 
are recorded simply as ‘cancer’, without 
specifying the causative agent. Despite a 
similar paucity of epidemiological data for 
many zoonotic diseases, the overwhelming 
consensus from participants was that the 
NZD community is now in a position 
where the focus must lie on moving 
forwards with control programmes and 
utilizing the available tools and data. 
Moving from advocacy to action  
for future zoonotic control 
Key messages from the session
•  Despite the progress made in 
tackling these diseases during the 
past decade, meeting participants 
recognized the large – but often still 
unquantiﬁed – burden placed by the 
NZDs on the poorest of the poor.
•  Control tools are available in most 
instances, although reﬁnement is 
still required.
•  Impressive examples of control 
programmes are now available, 
along with data demonstrating 
cost–effectiveness that can act as 
encouragement for other willing 
partners to embark upon NZD 
control programmes.
•  The global-level advocacy required 
for successful NZD control can be 
led by the FAO–OIE–WHO tripartite, 
coupled with strong political will  
at the national ministerial level.
•  Good examples exist to date of  
One Health operationalization for 
the NZDs in several countries;  
the Tripartite further supports 
individual counties in their wish to 
implement locally acceptable One 
Health mechanisms. 
•  Lack of funding is still a major 
barrier to control of some NZDs; 
hence novel investment opportunities 
should be explored where possible.
The last mile is the toughest to see these 
programmes through, [however] without  
the guys on the ground you’ll never get  
to that last mile.”
Dr Luke Gamble, WVS and Mission Rabies
Photo ©Franck Boué
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Fund control
Not surprisingly, access to funding 
remains an important barrier to NZD 
control. Positively, participants considered 
that the international NZD community  
had progressed substantially in the  
10 years since NZD1, with a shift in the 
funding priorities from research needs  
to operationalization and outcomes. 
However, as discussed earlier in this 
report, there are now opportunities to 
investigate innovative ﬁnance models 
such as DIBs, which may provide the 
required up-front investment in order to 
address these diseases in a sustainable 
way. Evidence of a successful economic 
case for the control of some zoonoses, 
such as that for brucellosis control in 
Mongolia (3), also helps provide a sound 
evidence base for investment.
There is a need to capitalize on speciﬁc 
drivers for disease control, with examples 
such as tsetse and rabies elimination from 
the tourist areas of Botswana and India 
respectively. Although it is important to 
look towards large donors for control 
programmes, it was also stressed that 
donor funding may in fact represent only  
a small proportion of national budgets in 
many countries, and that governments 
must have ownership of their programmes 
and be free to apply their own priorities.
Promote cross-sectoral collaboration 
and programmatic integration 
Cross-sectoral collaboration and 
integration at the international, national 
and local levels go hand in hand for  
NZD control (4). Participants agreed  
that cross-sectoral collaboration was  
of fundamental importance for moving 
forwards with the NZD agenda, with 
examples and opportunities for inter-
departmental collaboration identiﬁed at  
all levels. It was also recognized that in 
many instances, cross-sectoral working 
– particularly at the community level – is 
not possible without an enabling policy 
environment facilitated by those working 
at the various governmental levels. 
Integration may mean different things in 
different settings, but examples showed 
the potential for integrated approaches  
at various administrative levels. At an 
international level, there was a call for the 
integration of NZD control with the global 
health security agenda, which may assist 
in raising the proﬁle of these diseases and 
in turn the ability to access funding. At the 
implementation level, integration may take 
the form of ‘piggy-backing’ different 
strategies upon one another. An example 
was given of treating the ‘dog zoonoses 
cluster’ in Morocco where application of 
rabies vaccination, insecticidal collar for 
leishmaniasis control and anthelminthics 
against echinococcosis are being 
combined. It was made clear that WHO 
wishes to provide an evidence-based 
‘toolbox’ for NZD control, from which 
willing country partners may choose the 
tools that ﬁt their local situation.
Health education to encourage behaviour 
modiﬁcation was also shown to be a key 
part of many of the NZD control options, 
with participants acknowledging that 
communities require a certain level of 
knowledge in order to increase their  
stake in disease control and ensure 
sustainability of control programmes. 
Although empirical data are not available 
on the efﬁcacy of health education in 
many cases, it was considered that most 
of the currently available NZD control 
interventions require at least some level  
of human behaviour change; however,  
the difﬁculty and time periods required  
to achieve behaviour modiﬁcation were 
also acknowledged. It remains to be  
seen whether currently available 
resources are being used adequately to 
inﬂuence behaviour change. Platforms 
such as ADVANZ (http://www.advanz.
org/) provide an opportunity to collate all 
available resources for health education. 
Having a single, easily accessible 
repository for materials will allow for 
continual improvement in materials and  
an opportunity for open discussion about 
how they are best deployed in the ﬁeld. 
Closing remarks from this important ﬁnal 
session reiterated that One Health has 
now gained traction globally and, in 
conjunction with resolution WHA66.12 
(5), provides both the conceptual and 
policy frameworks for NZD prioritization 
and control via collaborative and 
integrated approaches. We are in a 
position where many control tools are now 
available: they may not yet be perfect but 
Neglected diseases are not new; however,  
they require a new approach. National 
health, agriculture and environmental 
ministries can be an important concentration 
of scientists and specialists that we should 
access through national budgets to use  
in the fight against these diseases.” 
Professor Idriss Alfaroukh, Directeur général, Institut de recherches  
en élevage pour le développement (IRED), Chad
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Conclusion
The participants of NZD4 acknowledged that tools are now available that 
allow for concerted efforts towards control of many NZDs. Resolution 
WHA66.12 provides the internationally agreed policy framework to support 
a new era in disease control and elimination programmes. 
The challenge has been set and the international NZD community – as 
researchers, funders or implementers, from medical, veterinary or 
transdisciplinary backgrounds, representing the public or private sectors 
within national or international organizations – all must now take 
responsibility for achieving the goals that have been set.
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are nevertheless ready for deployment. 
Moreover, there have been outstanding 
achievements for the control of some 
NZDs such as rabies and T.b. rhodesiense 
trypanosomiasis, which should serve as 
motivation for other diseases and countries. 
Rabies, in particular, has demonstrated 
the advocacy generated by public-private 
partnerships, and the importance of 
strong political will that feeds down to  
the community level in order to generate 
action for control. The methodology  
for this may, of course, vary from country  
to country, given the range of policy 
models available; however, it cannot  
be denied that the international NZD 
community now bears the responsibility 
for focussing attention on what needs  
to be done, and setting time-linked goals 
for which it is accountable. 
Put simply, if you want to combat poverty, 
what greater gift to give communities than 
their health?” 
Prof Sue Welburn, ICONZ Coordinator, University of Edinburgh
Photo ©Sue Welburn
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87. Professor Charles Waiswa
Makerere University
Uganda 
Email: cwaiswa@vetmed.mak.ac.ug;
88. Professor Sue Welburn 
The University of Edinburgh
United Kingdom
Email: sue.welburn@ed.ac.uk
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Ministry of Agriculture, Forestry and Fisheries
Japan
Email: animal_health@nm.maff.go.jp; 
yuichi_kishita@nm.maff.go.jp
91. Dr Nguyen Thu Thuy
Ministry of Agriculture and Rural Development 
Vietnam
Email: thuynt.dah@gmail.com
OBSERVERS
92. Andrea Arancibia
Sanoﬁ Pasteur
France
Email: Andrea.Arancibia@sanoﬁpasteur.com
93. Dr Mathias B. Bonk
Global Health Consultant
Germany
Email: mathias.bonk@thinkglobalhealth.de
94. Dr Paul Coleman
H2O Venture Partners 
United Kingdom
Email: paul.coleman@h2ovp.com
95. Dr Robert Hnatuk
Thermo Fisher Scientiﬁc
United States of America
Email: Robert.hnatuk@thermoﬁsher.com
96. Lyn Morgan
Sanoﬁ Pasteur
France
Email: Lyn.Morgan@sanoﬁpasteur.com
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100. Dr Valentina Picot 
Fondation Merieux 
France
Email: valentina.picot@fondation-merieux.org
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Janssen Global Services of Johnson & Johnson
USA
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109. Dr Lea Knopf
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UN and Other International Organizations
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ADVANZ  Advocacy for Neglected Zoonotic Diseases
AFRICOLEISH   EU project to develop effective treatment for leishmaniasis in East Africa
ANTIGONE  EU project ‘Anticipating the global onset of novel epidemics’ 
ASKLEPIOS   EU project ‘Advanced Studies towards Knowledge on Lyssavirus Encephalitis 
Pathogenesis Improving Options for Survival’
BBSRC  UK Biotechnology and Biological Sciences Research Council 
BMGF  Bill & Melinda Gates Foundation
CCH  Crimean–Congo haemorrhagic fever
DBM   dog bite management 
DEFRA  Department for Environment, Food and Rural Affairs
DEVCO   Development and Cooperation 
DFID  UK Department for International Development
DIB  development investment bond
DISCONTOOLS  research prioritization for animal disease control
EU  European Union
FAO  Food and Agriculture Organization of the United Nations
FP7  Seventh Research Framework Programme 
GARC  Global Alliance for Rabies Control
HERACLES  European register of cystic echinococcus
HPED  highly pathogenic and emerging diseases
ICONZ  Integrated Control of Neglected Zoonoses
IDSR  Integrated Disease Surveillance and Response 
MDA  mass drug administration
MDV   mass dog vaccination 
NZD  neglected zoonotic disease
OH-NEXTGEN  Training of the One Health Next Scientiﬁc Generation in the Sahel and Maghreb
OIE  World Organisation for Animal Health
PEP   post-exposure prophylaxis
PRP   Partners for Rabies Prevention
RFP  Research Framework Programme of the European Union
SARE  step-wise approach towards rabies elimination
SIB  social impact bond 
SOP  standard operating procedure
STAR-IDAZ Global Network for Animal Disease Research
VETGOV   veterinary governance in Africa 
WHO  World Health Organization
ZELS  Zoonoses and Emerging Livestock Systems 
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